StockData
InnovAge Holding Corp. logo

InnovAge Holding Corp. (INNV) stock

INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3056% above fair value
$8.91+0.00 (0.00%)

Close on Nov 19, 2026Market cap $1.22BP/E –Yield –

InnovAge free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

InnovAge's free cash flow for the twelve months ending Jun 30, 2026 was $50.41M, up 89.5% year over year. For fiscal 2026 it was $50.41M, up 89.5% from the year before. The highest annual figure on record is $50.41M in fiscal 2026.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$50.41M+89.5%
FY2025Jun 30, 2025$26.60M–
FY2024Jun 30, 2024-$44.81M–
FY2023Jun 30, 2023-$3.12M–
FY2022Jun 30, 2022-$10.94M–
FY2021Jun 30, 2021-$25.09M-178.4%
FY2020Jun 30, 2020$31.98M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$17.02M+85.4%
Q3 FY2026CQ1 2026Mar 31, 2026$14.54M-33.1%
Q2 FY2026CQ4 2025Dec 31, 2025$19.00M+251.2%
Q1 FY2026CQ3 2025Sep 30, 2025-$153.00K–
Q4 FY2025CQ2 2025Jun 30, 2025$9.18M–
Q3 FY2025CQ1 2025Mar 31, 2025$21.73M+611.0%
Q2 FY2025CQ4 2024Dec 31, 2024$5.41M–
Q1 FY2025CQ3 2024Sep 30, 2024-$9.72M–
Q4 FY2024CQ2 2024Jun 30, 2024-$1.43M-115.7%
Q3 FY2024CQ1 2024Mar 31, 2024$3.06M-87.5%
Q2 FY2024CQ4 2023Dec 31, 2023-$10.88M–
Q1 FY2024CQ3 2023Sep 30, 2023-$35.56M-751.1%
Q4 FY2023CQ2 2023Jun 30, 2023$9.13M–
Q3 FY2023CQ1 2023Mar 31, 2023$24.38M–
Q2 FY2023CQ4 2022Dec 31, 2022-$42.08M-1868.9%
Q1 FY2023CQ3 2022Sep 30, 2022$5.46M-68.8%
Q4 FY2022CQ2 2022Jun 30, 2022-$14.85M-346.7%
Q3 FY2022CQ1 2022Mar 31, 2022-$15.98M–
Q2 FY2022CQ4 2021Dec 31, 2021$2.38M-77.3%
Q1 FY2022CQ3 2021Sep 30, 2021$17.52M–
Q4 FY2021CQ2 2021Jun 30, 2021$6.02M-71.4%
Q3 FY2021CQ1 2021Mar 31, 2021-$18.90M–
Q2 FY2021CQ4 2020Dec 31, 2020$10.48M–
Q1 FY2021CQ3 2020Sep 30, 2020-$22.69M–
Q4 FY2020CQ2 2020Jun 30, 2020$21.05M–

More InnovAge figures

See a number that looks wrong?